Health officials have been watching for any safety issues with RSV vaccines in older adults. This report looks at safety monitoring during the first year these vaccines were recommended for people aged 60 and older in the United States.
The monitoring did not identify any major safety concerns during this initial period. Researchers collected and reviewed safety reports from various sources to look for patterns of problems.
It's important to understand this is early safety surveillance, not a complete long-term study. The monitoring will continue as more people receive the vaccine over time. This type of ongoing safety checking is standard for all new vaccines.